David P. Meeker, Executive VP, Chief Operating Officer at GENZYME CORP (GENZ), sold 16,488 shares at $49.06 ($809K) on 2010-05-21, disclosed to the SEC on 2010-05-25.
Scheduled sale ($809k) by Executive VP, Chief Operating Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| Filing → |
| RYTM | SELL | 2025-02-19 | $1.1M | — | Filing → |
| RYTM | SELL | 2025-02-04 | $508K | — | Filing → |
| TRVI | SELL | 2024-08-29 | $13K | — | Filing → |